TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 307 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $412,000 | -94.5% | 22,600 | -94.5% | 0.02% | -94.1% |
| Q4 2020 | $7,532,000 | -3.7% | 413,809 | -5.6% | 0.29% | -21.9% |
| Q3 2020 | $7,820,000 | -3.8% | 438,409 | -3.2% | 0.37% | -19.6% |
| Q2 2020 | $8,125,000 | +38.3% | 453,058 | +17.1% | 0.46% | -0.6% |
| Q1 2020 | $5,875,000 | -16.7% | 386,960 | +8.3% | 0.46% | +18.4% |
| Q4 2019 | $7,052,000 | +35.5% | 357,386 | +18.1% | 0.39% | +17.1% |
| Q3 2019 | $5,205,000 | -10.9% | 302,598 | -8.3% | 0.33% | -0.6% |
| Q2 2019 | $5,841,000 | +9.1% | 330,072 | +25.5% | 0.34% | +4.3% |
| Q1 2019 | $5,356,000 | – | 262,911 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |